Novartis India ownership shifts to ChrysCapital-led group; board reshuffled
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.4 pts less than Nifty Microcap 250 and 0.3 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Novartis AG sold its entire 1.745 crore equity stake to a ChrysCapital-led consortium (WaveRise, ChrysCapital Fund X, Two Infinity Partners). Novartis AG reclassified from promoter to public. Open Offer concluded July 29, 2026. Six directors resigned including CFO Shilpa Joshi, Chairperson Christopher Snook, and three independent directors. Six new directors appointed on the new board.
Major ownership change. New PE-backed board in place. Watch for strategic shifts and management changes under new promoters.